research Wharton's Jelly-Derived Mesenchymal Stem Cells in the Treatment of Four Patients with Alopecia Areata
Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.
Search
for
Sort by
Research
150-180 / 1000+ results 
research Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase I Study
RCS-01 therapy is safe and may improve skin structure by affecting gene expression.
research Diseases of the Skin: Treatment of Scalp Disorders
The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.
research Platelet-Rich Plasma in Melasma: A Systematic Review
Platelet-rich plasma (PRP) can significantly improve melasma, a skin pigmentation disorder, but may not add benefits when used with certain other treatments.
research Evaluation of Adding Platelet-Rich Plasma to Combined Medical Therapy in Androgenetic Alopecia
Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.
research Special Focus Issue: Transdermal, Topical, and Follicular Drug Delivery Systems
New drug delivery systems improve treatment effectiveness and patient experience.
research Nasal Sporotrichosis in Children
Three children with nasal fungal infections were successfully treated with potassium iodide and sometimes itraconazole.
research Activated Platelet Rich Plasma Versus Non-Activated Platelet Rich Plasma in the Treatment of Alopecia Areata
Activated and non-activated PRP are equally safe and effective for treating alopecia areata.
research Comment on 'Treatment of Male Pattern Alopecia with Platelet-Rich Plasma: A Double-Blind Controlled Study with Analysis of Platelet Number and Growth Factor Levels'
The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.
research Permanent Hair Loss in a Patient with Hypersensitivity to Intralesional Triamcinolone Injection
A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.
research Sweat Hypersensitivity-Induced Urticaria and Sebaceous Adenitis in an American Saddlebred
Sweat hypersensitivity can cause severe skin issues in horses.
research Refractory Pruritic Fox-Fordyce Disease Successfully Treated With Botulinum Toxin Type A
Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.
research A Comparative Study of Efficacy of 5% Minoxidil and 5% Minoxidil Plus Platelet-Rich Plasma in the Same Patient for Treatment of Androgenetic Alopecia
Combining 5% minoxidil with platelet-rich plasma is more effective for hair loss than minoxidil alone.
research Clinical Pathology in Equine Dermatology
The document concludes that using the right diagnostic methods and careful sample handling is crucial for accurately diagnosing horse skin diseases.
research Mesotherapy with Bicalutamide for Female Pattern Hair Loss
Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
research Dermoscopy: A Versatile Tool to Bust Quackery
Dermoscopy helps diagnose skin issues and warns against unqualified treatments.
research Comparative Characteristics of the Effectiveness of Drugs for the Treatment of Alopecia Areata in Childhood
Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.
research Role of Platelet-Rich Plasma Therapy in the Treatment of Alopecia Areata and Atrophic Acne Scars
PRP therapy effectively treats alopecia areata and atrophic acne scars.
research Split-Scalp Pilot Study to Evaluate Effectiveness of Minoxidil 0.5% MMP® Versus Topical Minoxidil 5% in the Treatment of Female Pattern Hair Loss
Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.
research A Randomized, Double-Blind, Placebo-Controlled, Half-Head Study to Evaluate the Effects of Platelet-Rich Plasma on Androgenetic Alopecia
PRP injections did not significantly improve hair growth in men with androgenetic alopecia.
research Efficacy and Tolerability of a Hyaluronic Acid-Based Extracellular Matrix for Labia Majora Rejuvenation and Augmentation: A Pilot Study
Sunekos® effectively improves labia majora appearance and is well-tolerated.
research Efficacy of Dr. SKS Hair Booster Serum for the Treatment of Hair Loss in COVID-19 Induced Persistent Telogen Effluvium
Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
research Treatment with Injectable Platelet-Rich Fibrin in a Rat Model of Melasma
Injectable platelet-rich fibrin can safely and effectively treat melasma.
research Systematic Review of Mesotherapy for the Treatment of Hair Loss
Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.
research Botulinum Toxin A as an Alternative Treatment for Folliculitis Decalvans
Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.
research Typical Morphological Characteristics of the Skin Structure of the Hair Part of the Normal Human Head and with Hair Loss
Androgenic alopecia causes hair follicle degradation and skin restructuring, but some hair elements remain.
research Feasibility of Platelet Rich Plasma Use in Hair Transplantation for Treatment of Post Burn Scar
Using Platelet Rich Plasma with hair transplants is effective for treating hair loss due to burns.
research Telogen Effluvium Post COVID-19 Infection: A Narrative Review
COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.
research Supplementary Material for: Activated Platelet-Rich Plasma Versus Non-Activated Platelet-Rich Plasma in the Treatment of Alopecia Areata
Activated PRP is unnecessary for treating alopecia areata; both activated and non-activated PRP are equally effective and safe.
research Exploring the Potential of the Novel IFNγ Aptamer TAGX-0003 as a Treatment for Alopecia Areata in Pre-Clinical Models
The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.